Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma

Abstract Objectives Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squam...

Full description

Saved in:
Bibliographic Details
Published inAmerican journal of clinical pathology Vol. 153; no. 5; pp. 618 - 629
Main Authors Li, Hao, Yang, Lei-Lei, Wu, Cong-Cong, Xiao, Yao, Mao, Liang, Chen, Lei, Zhang, Wen-Feng, Sun, Zhi-Jun
Format Journal Article
LanguageEnglish
Published US Oxford University Press 15.04.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Objectives Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC). Methods Immunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. Results IFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity. Conclusions IFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers.
AbstractList The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed.
Abstract Objectives Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC). Methods Immunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. Results IFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity. Conclusions IFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers.
Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC). Immunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. IFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity. IFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers.
Objectives Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC). Methods Immunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. Results IFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity. Conclusions IFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers.
Objectives: Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC). Methods: Immunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. Results: IFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity. Conclusions: IFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers. Key Words: IFIT1; IFITM3; Head and neck squamous cell carcinoma; Prognosis; Macrophage
OBJECTIVESInterferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC). METHODSImmunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. RESULTSIFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity. CONCLUSIONSIFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers.
Audience Professional
Academic
Author Wu, Cong-Cong
Zhang, Wen-Feng
Li, Hao
Xiao, Yao
Chen, Lei
Yang, Lei-Lei
Mao, Liang
Sun, Zhi-Jun
Author_xml – sequence: 1
  givenname: Hao
  surname: Li
  fullname: Li, Hao
  organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China
– sequence: 2
  givenname: Lei-Lei
  surname: Yang
  fullname: Yang, Lei-Lei
  organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China
– sequence: 3
  givenname: Cong-Cong
  surname: Wu
  fullname: Wu, Cong-Cong
  organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China
– sequence: 4
  givenname: Yao
  surname: Xiao
  fullname: Xiao, Yao
  organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China
– sequence: 5
  givenname: Liang
  surname: Mao
  fullname: Mao, Liang
  organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China
– sequence: 6
  givenname: Lei
  surname: Chen
  fullname: Chen, Lei
  organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China
– sequence: 7
  givenname: Wen-Feng
  surname: Zhang
  fullname: Zhang, Wen-Feng
  organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China
– sequence: 8
  givenname: Zhi-Jun
  orcidid: 0000-0003-0932-8013
  surname: Sun
  fullname: Sun, Zhi-Jun
  email: sunzj@whu.edu.cn
  organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31977029$$D View this record in MEDLINE/PubMed
BookMark eNp9kd1LHDEUxYModdU--S6BQhHKaL5mMnmUxe0u2FZQ-ySEbJKRrDPJbLID1b_erKsVi5TAzeXe3z0cOHtg2wdvATjE6AQjQU_VQvenavlIULkFRlgwWnBOyDYYIYRIITCnu2AvpQVCmNSIfQK7FAvOEREjcHv-p482JRc8VN7AyxjufEgrp-Fv1Q4WhgbOJrNr_Lxddz8odB5OrTLPo59W38Or5aC6MCQ4tm0Lxypq50OnDsBOo9pkP7_8--Bmcn49nhYXv77PxmcXhWYlWRWEcoLntS2J0XOqkc6VcF1TzXBVG2bqxihkuRb1HJeGMis4qlmDuKaUK0P3wfFGt49hOdi0kp1LOltR3mZXklDGSMUorzL65R90EYbosztJGClLjgXCb9Sdaq10vgmrqPRaVJ5V2TOrOBWZOvmAys_YzukcUuPy_N3Bt82BjiGlaBvZR9ep-CAxkuss5TpLucky00cvVod5Z81f9jW8DHzdAGHo_6v0BGyupYc
CitedBy_id crossref_primary_10_3390_cells10051171
crossref_primary_10_1007_s12032_024_02308_6
crossref_primary_10_1186_s13062_023_00422_5
crossref_primary_10_1007_s42979_022_01492_4
crossref_primary_10_3389_fimmu_2022_1042368
crossref_primary_10_3389_fonc_2020_593245
crossref_primary_10_1186_s12957_023_03274_5
crossref_primary_10_1038_s41598_024_51427_7
crossref_primary_10_1007_s12033_021_00439_z
crossref_primary_10_3389_fonc_2020_607622
crossref_primary_10_1080_21655979_2021_2024333
crossref_primary_10_2147_IDR_S328197
crossref_primary_10_1016_j_omto_2021_07_002
Cites_doi 10.1007/s12094-012-0991-z
10.3892/or.2014.3522
10.1007/s12094-017-1776-1
10.1038/nrc1782
10.1093/ajcp/aqy029
10.1038/ncomms14391
10.1200/JCO.2015.61.1509
10.1186/1471-2377-13-210
10.1158/1078-0432.CCR-10-2729
10.1038/nri1961
10.1002/hed.25507
10.1038/nri3344
10.1093/nar/gkx247
10.1111/1759-7714.12488
10.1038/nrc2090
10.1007/s12094-012-0867-2
10.1006/geno.1994.1591
10.3322/caac.21442
10.1371/journal.pone.0051862
10.1038/nri2326
10.1016/j.oraloncology.2017.05.004
10.1038/s41568-019-0106-z
10.1016/j.immuni.2016.05.002
10.1016/j.ccell.2015.02.015
10.1111/tbj.12097
10.1038/nrclinonc.2017.101
10.1080/000164802760057527
10.1038/s41571-018-0142-8
10.1016/0092-8674(84)90270-8
10.3892/or.2013.2428
10.1038/nrc.2017.17
10.1073/pnas.0809242105
10.1038/onc.2011.393
10.18632/oncotarget.17547
10.18632/oncotarget.13328
10.1111/apm.12692
10.3389/fonc.2019.00091
10.1002/hed.24406
10.1007/s00262-017-1968-0
10.1007/s00262-016-1867-9
10.1038/ni.2048
10.1038/nature00927
10.18632/oncotarget.5955
10.1002/ijc.29210
10.1016/j.immuni.2015.09.001
10.1038/nri3581
10.1111/j.1349-7006.2012.02211.x
10.1016/j.oraloncology.2011.03.007
ContentType Journal Article
Copyright American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020
American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
COPYRIGHT 2020 Oxford University Press
American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
Copyright_xml – notice: American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020
– notice: American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
– notice: COPYRIGHT 2020 Oxford University Press
– notice: American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com
DBID NPM
AAYXX
CITATION
3V.
7RV
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7P
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1093/ajcp/aqz205
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

PubMed
ProQuest Central Student

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1943-7722
EndPage 629
ExternalDocumentID A645246739
10_1093_ajcp_aqz205
31977029
10.1093/ajcp/aqz205
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
.55
0R~
1CY
23M
2WC
4.4
48X
53G
5GY
5RE
5WD
6J9
7RV
7X7
88E
8FE
8FH
8FI
8FJ
AABZA
AACZT
AAIMJ
AAMDB
AAMVS
AAPQZ
AAPXW
AAQQT
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
AAWTL
ABCQX
ABEUO
ABIXL
ABJNI
ABLJU
ABMNT
ABNHQ
ABPPZ
ABPTD
ABQNK
ABUWG
ABWST
ABXVV
ACGFO
ACGFS
ACPRK
ACUFI
ACUTJ
ACYHN
ADBBV
ADFRT
ADGZP
ADHKW
ADIPN
ADQBN
ADRTK
ADVEK
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFGWE
AFIYH
AFKRA
AFOFC
AFXEN
AGINJ
AGQXC
AGSYK
AGUTN
AHMBA
AJEEA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
ARIXL
ATGXG
AVWKF
AYOIW
BAWUL
BAYMD
BBNVY
BCRHZ
BENPR
BEYMZ
BHONS
BHPHI
BKEYQ
BPHCQ
BQDIO
BSWAC
BTRTY
BVRKM
BVXVI
C45
CCPQU
CDBKE
CS3
DAKXR
DIK
DILTD
E3Z
EBS
ENERS
EX3
F5P
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
FYUFA
GAUVT
GJXCC
GX1
H13
HCIFZ
HMCUK
IAO
IH2
IHR
INH
ITC
J21
KBUDW
KOP
KQ8
KSI
KSN
L7B
LID
LK8
LSO
M1P
M7P
MHKGH
NAPCQ
NLBLG
NOMLY
NOYVH
O9-
OAUYM
OAWHX
OBOKY
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P6G
PAFKI
PEELM
PQQKQ
PROAC
PSQYO
ROX
ROZ
RUSNO
SJN
TEORI
TJX
TLC
TPV
TR2
TWZ
UKHRP
W8F
WH7
WOW
X7M
YAYTL
YKOAZ
YXANX
EMB
NPM
AAYXX
CITATION
AABJS
AABMN
AAESY
ABSAR
ABXZS
ACIMA
ADEIU
ADJQC
ADORX
ADQLU
ADRIX
AHPSJ
AIKOY
AIMBJ
ALXQX
ASMCH
AZQFJ
BGYMP
BYORX
CASEJ
DPPUQ
ZA5
3V.
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c452t-23721b8e52dcb3c0ccb327c83c4168d4d8fda0e7c98b15d34e97084f07c337ad3
IEDL.DBID 7X7
ISSN 0002-9173
IngestDate Sat Oct 05 05:17:35 EDT 2024
Thu Oct 10 21:51:28 EDT 2024
Thu Feb 22 23:55:03 EST 2024
Fri Feb 02 04:18:10 EST 2024
Thu Sep 26 18:41:43 EDT 2024
Wed Oct 16 00:45:53 EDT 2024
Wed Sep 11 04:40:05 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords IFITM3
Head and neck squamous cell carcinoma
Prognosis
IFIT1
Macrophage
Language English
License This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c452t-23721b8e52dcb3c0ccb327c83c4168d4d8fda0e7c98b15d34e97084f07c337ad3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-0932-8013
OpenAccessLink https://academic.oup.com/ajcp/article-pdf/153/5/618/33049421/aqz205.pdf
PMID 31977029
PQID 2425571901
PQPubID 586299
PageCount 12
ParticipantIDs proquest_miscellaneous_2344264376
proquest_journals_2425571901
gale_infotracmisc_A645246739
gale_infotracacademiconefile_A645246739
crossref_primary_10_1093_ajcp_aqz205
pubmed_primary_31977029
oup_primary_10_1093_ajcp_aqz205
PublicationCentury 2000
PublicationDate 2020-04-15
PublicationDateYYYYMMDD 2020-04-15
PublicationDate_xml – month: 04
  year: 2020
  text: 2020-04-15
  day: 15
PublicationDecade 2020
PublicationPlace US
PublicationPlace_xml – name: US
– name: England
– name: Chicago
PublicationTitle American journal of clinical pathology
PublicationTitleAlternate Am J Clin Pathol
PublicationYear 2020
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Müller (2020041521553931400_CIT0044) 2017; 8
Grimm (2020041521553931400_CIT0006) 2012; 14
De Marzo (2020041521553931400_CIT0050) 2007; 7
Yu (2020041521553931400_CIT0030) 2015; 6
Li (2020041521553931400_CIT0040) 2019;25:157-167
Brierley (2020041521553931400_CIT0026) 2016
Li (2020041521553931400_CIT0019) 2011; 17
Friedman (2020041521553931400_CIT0015) 1984; 38
Geng (2020041521553931400_CIT0051) 2019; 9
Hu (2020041521553931400_CIT0017) 2014; 32
Saitou (2020041521553931400_CIT0016) 2002; 418
Pichlmair (2020041521553931400_CIT0012) 2011; 12
Weichselbaum (2020041521553931400_CIT0014) 2008; 105
Cui (2020041521553931400_CIT0022) 2015; 37
Maroto (2020041521553931400_CIT0034) 2013; 15
Ryu (2020041521553931400_CIT0047) 2019; 41
Diamond (2020041521553931400_CIT0009) 2013; 13
Tang (2020041521553931400_CIT0027) 2017; 45
Ferlay (2020041521553931400_CIT0002) 2015; 136
Jønsson (2020041521553931400_CIT0048) 2017; 8
Iglesias Docampo (2020041521553931400_CIT0005) 2018; 20
Bluyssen (2020041521553931400_CIT0011) 1994; 24
Wu (2020041521553931400_CIT0032) 2017; 66
Ali (2020041521553931400_CIT0003) 2017; 70
Cheriyath (2020041521553931400_CIT0037) 2012; 31
de Visser (2020041521553931400_CIT0036) 2006; 6
Jia (2020041521553931400_CIT0021) 2017; 8
Ivashkiv (2020041521553931400_CIT0010) 2014; 14
Biswas (2020041521553931400_CIT0007) 2015; 43
Laimer (2020041521553931400_CIT0033) 2011; 47
Gotwals (2020041521553931400_CIT0045) 2017; 17
Inagi (2020041521553931400_CIT0004) 2002
Li (2020041521553931400_CIT0028) 2018; 150
Siegel (2020041521553931400_CIT0001) 2018; 68
Han (2020041521553931400_CIT0049) 2011; 25
Piccaluga (2020041521553931400_CIT0039) 2017; 125
Dunn (2020041521553931400_CIT0008) 2006; 6
Zou (2020041521553931400_CIT0043) 2008; 8
O’Donnell (2020041521553931400_CIT0052) 2019; 16
Danish (2020041521553931400_CIT0035) 2013; 19
Wu (2020041521553931400_CIT0031) 2016; 65
Nguyen (2020041521553931400_CIT0042) 2016; 38
Kondo (2020041521553931400_CIT0038) 2012; 103
Lemos (2020041521553931400_CIT0025) 2019; 19
Budczies (2020041521553931400_CIT0029) 2012; 7
Visser (2020041521553931400_CIT0013) 2017; 8
Zhao (2020041521553931400_CIT0020) 2013; 13
Fridman (2020041521553931400_CIT0023) 2017; 14
Ferris (2020041521553931400_CIT0041) 2015; 33
Yang (2020041521553931400_CIT0018) 2013; 30
Schildberg (2020041521553931400_CIT0024) 2016; 44
Ruffell (2020041521553931400_CIT0046) 2015; 27
References_xml – volume: 15
  start-page: 698
  year: 2013
  ident: 2020041521553931400_CIT0034
  article-title: Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC)
  publication-title: Clin Transl Oncol.
  doi: 10.1007/s12094-012-0991-z
  contributor:
    fullname: Maroto
– volume: 32
  start-page: 2648
  year: 2014
  ident: 2020041521553931400_CIT0017
  article-title: Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer
  publication-title: Oncol Rep.
  doi: 10.3892/or.2014.3522
  contributor:
    fullname: Hu
– volume: 20
  start-page: 75
  year: 2018
  ident: 2020041521553931400_CIT0005
  article-title: SEOM clinical guidelines for the treatment of head and neck cancer (2017)
  publication-title: Clin Transl Oncol.
  doi: 10.1007/s12094-017-1776-1
  contributor:
    fullname: Iglesias Docampo
– volume: 6
  start-page: 24
  year: 2006
  ident: 2020041521553931400_CIT0036
  article-title: Paradoxical roles of the immune system during cancer development
  publication-title: Nat Rev Cancer.
  doi: 10.1038/nrc1782
  contributor:
    fullname: de Visser
– volume: 150
  start-page: 74
  year: 2018
  ident: 2020041521553931400_CIT0028
  article-title: Overexpression of Golgi phosphoprotein 2 is associated with poor prognosis in oral squamous cell carcinoma
  publication-title: Am J Clin Pathol.
  doi: 10.1093/ajcp/aqy029
  contributor:
    fullname: Li
– volume: 8
  start-page: 14391
  year: 2017
  ident: 2020041521553931400_CIT0048
  article-title: IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP
  publication-title: Nat Commun.
  doi: 10.1038/ncomms14391
  contributor:
    fullname: Jønsson
– volume: 33
  start-page: 3293
  year: 2015
  ident: 2020041521553931400_CIT0041
  article-title: Immunology and immunotherapy of head and neck cancer
  publication-title: J Clin Oncol.
  doi: 10.1200/JCO.2015.61.1509
  contributor:
    fullname: Ferris
– volume: 13
  start-page: 210
  year: 2013
  ident: 2020041521553931400_CIT0020
  article-title: The role of IFITM3 in the growth and migration of human glioma cells
  publication-title: BMC Neurol.
  doi: 10.1186/1471-2377-13-210
  contributor:
    fullname: Zhao
– volume: 17
  start-page: 3558
  year: 2011
  ident: 2020041521553931400_CIT0019
  article-title: KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis
  publication-title: Clin Cancer Res.
  doi: 10.1158/1078-0432.CCR-10-2729
  contributor:
    fullname: Li
– volume: 6
  start-page: 836
  year: 2006
  ident: 2020041521553931400_CIT0008
  article-title: Interferons, immunity and cancer immunoediting
  publication-title: Nat Rev Immunol.
  doi: 10.1038/nri1961
  contributor:
    fullname: Dunn
– volume: 37
  start-page: 352
  year: 2015
  ident: 2020041521553931400_CIT0022
  article-title: Expression of IFITM3 in colorectal carcinoma and its clinical significance
  publication-title: Zhonghua Zhong Liu Za Zhi.
  contributor:
    fullname: Cui
– volume: 41
  start-page: 198
  year: 2019
  ident: 2020041521553931400_CIT0047
  article-title: Characterization of head and neck squamous cell carcinoma arising in young patients: particular focus on molecular alteration and tumor immunity
  publication-title: Head Neck.
  doi: 10.1002/hed.25507
  contributor:
    fullname: Ryu
– volume: 13
  start-page: 46
  year: 2013
  ident: 2020041521553931400_CIT0009
  article-title: The broad-spectrum antiviral functions of IFIT and IFITM proteins
  publication-title: Nat Rev Immunol.
  doi: 10.1038/nri3344
  contributor:
    fullname: Diamond
– volume: 45
  start-page: W98
  year: 2017
  ident: 2020041521553931400_CIT0027
  article-title: GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkx247
  contributor:
    fullname: Tang
– volume: 8
  start-page: 592
  year: 2017
  ident: 2020041521553931400_CIT0021
  article-title: Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy
  publication-title: Thorac Cancer.
  doi: 10.1111/1759-7714.12488
  contributor:
    fullname: Jia
– volume: 7
  start-page: 256
  year: 2007
  ident: 2020041521553931400_CIT0050
  article-title: Inflammation in prostate carcinogenesis
  publication-title: Nat Rev Cancer.
  doi: 10.1038/nrc2090
  contributor:
    fullname: De Marzo
– volume: 14
  start-page: 870
  year: 2012
  ident: 2020041521553931400_CIT0006
  article-title: Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC
  publication-title: Clin Transl Oncol.
  doi: 10.1007/s12094-012-0867-2
  contributor:
    fullname: Grimm
– volume: 24
  start-page: 137
  year: 1994
  ident: 2020041521553931400_CIT0011
  article-title: Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family
  publication-title: Genomics.
  doi: 10.1006/geno.1994.1591
  contributor:
    fullname: Bluyssen
– volume: 68
  start-page: 7
  year: 2018
  ident: 2020041521553931400_CIT0001
  article-title: Cancer statistics, 2018
  publication-title: CA Cancer J Clin.
  doi: 10.3322/caac.21442
  contributor:
    fullname: Siegel
– volume: 7
  start-page: e51862
  year: 2012
  ident: 2020041521553931400_CIT0029
  article-title: Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization
  publication-title: PLoS One.
  doi: 10.1371/journal.pone.0051862
  contributor:
    fullname: Budczies
– volume: 8
  start-page: 467
  year: 2008
  ident: 2020041521553931400_CIT0043
  article-title: Inhibitory B7-family molecules in the tumour microenvironment
  publication-title: Nat Rev Immunol.
  doi: 10.1038/nri2326
  contributor:
    fullname: Zou
– volume: 70
  start-page: 23
  year: 2017
  ident: 2020041521553931400_CIT0003
  article-title: Genetic etiology of oral cancer
  publication-title: Oral Oncol.
  doi: 10.1016/j.oraloncology.2017.05.004
  contributor:
    fullname: Ali
– volume: 19
  start-page: 162
  year: 2019
  ident: 2020041521553931400_CIT0025
  article-title: Immune control by amino acid catabolism during tumorigenesis and therapy
  publication-title: Nat Rev Cancer.
  doi: 10.1038/s41568-019-0106-z
  contributor:
    fullname: Lemos
– volume: 44
  start-page: 955
  year: 2016
  ident: 2020041521553931400_CIT0024
  article-title: Coinhibitory pathways in the B7-CD28 ligand-receptor family
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2016.05.002
  contributor:
    fullname: Schildberg
– volume: 27
  start-page: 462
  year: 2015
  ident: 2020041521553931400_CIT0046
  article-title: Macrophages and therapeutic resistance in cancer
  publication-title: Cancer Cell.
  doi: 10.1016/j.ccell.2015.02.015
  contributor:
    fullname: Ruffell
– volume: 25
  start-page: 531
  year: 2011
  ident: 2020041521553931400_CIT0049
  article-title: IFITM6 expression is increased in macrophages of tumor-bearing mice
  publication-title: Oncol Rep.
  contributor:
    fullname: Han
– volume: 19
  start-page: 231
  year: 2013
  ident: 2020041521553931400_CIT0035
  article-title: Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT)
  publication-title: Breast J.
  doi: 10.1111/tbj.12097
  contributor:
    fullname: Danish
– volume-title: TNM Classification of Malignant Tumours
  year: 2016
  ident: 2020041521553931400_CIT0026
  contributor:
    fullname: Brierley
– volume: 14
  start-page: 717
  year: 2017
  ident: 2020041521553931400_CIT0023
  article-title: The immune contexture in cancer prognosis and treatment
  publication-title: Nat Rev Clin Oncol.
  doi: 10.1038/nrclinonc.2017.101
  contributor:
    fullname: Fridman
– start-page: 25
  year: 2002
  ident: 2020041521553931400_CIT0004
  article-title: Treatment effects in patients with squamous cell carcinoma of the oral cavity
  publication-title: Acta Otolaryngol Suppl.
  doi: 10.1080/000164802760057527
  contributor:
    fullname: Inagi
– volume: 16
  start-page: 151
  year: 2019
  ident: 2020041521553931400_CIT0052
  article-title: Cancer immunoediting and resistance to T cell-based immunotherapy
  publication-title: Nat Rev Clin Oncol.
  doi: 10.1038/s41571-018-0142-8
  contributor:
    fullname: O’Donnell
– volume: 38
  start-page: 745
  year: 1984
  ident: 2020041521553931400_CIT0015
  article-title: Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells
  publication-title: Cell.
  doi: 10.1016/0092-8674(84)90270-8
  contributor:
    fullname: Friedman
– volume: 30
  start-page: 171
  year: 2013
  ident: 2020041521553931400_CIT0018
  article-title: Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle
  publication-title: Oncol Rep.
  doi: 10.3892/or.2013.2428
  contributor:
    fullname: Yang
– volume: 17
  start-page: 286
  year: 2017
  ident: 2020041521553931400_CIT0045
  article-title: Prospects for combining targeted and conventional cancer therapy with immunotherapy
  publication-title: Nat Rev Cancer.
  doi: 10.1038/nrc.2017.17
  contributor:
    fullname: Gotwals
– volume: 105
  start-page: 18490
  year: 2008
  ident: 2020041521553931400_CIT0014
  article-title: An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
  publication-title: Proc Natl Acad Sci U S A.
  doi: 10.1073/pnas.0809242105
  contributor:
    fullname: Weichselbaum
– year: 2019;25:157-167
  ident: 2020041521553931400_CIT0040
  article-title: DDR2 and IFITM1 are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas
  publication-title: Pathol Oncol Res.
  contributor:
    fullname: Li
– volume: 31
  start-page: 2222
  year: 2012
  ident: 2020041521553931400_CIT0037
  article-title: G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer
  publication-title: Oncogene.
  doi: 10.1038/onc.2011.393
  contributor:
    fullname: Cheriyath
– volume: 8
  start-page: 52889
  year: 2017
  ident: 2020041521553931400_CIT0044
  article-title: PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.17547
  contributor:
    fullname: Müller
– volume: 8
  start-page: 5566
  year: 2017
  ident: 2020041521553931400_CIT0013
  article-title: Prognostic gene expression profiling in esophageal cancer: a systematic review
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.13328
  contributor:
    fullname: Visser
– volume: 125
  start-page: 511
  year: 2017
  ident: 2020041521553931400_CIT0039
  article-title: IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia
  publication-title: Apmis.
  doi: 10.1111/apm.12692
  contributor:
    fullname: Piccaluga
– volume: 9
  start-page: 91
  year: 2019
  ident: 2020041521553931400_CIT0051
  article-title: Identification of potential candidate genes of oral cancer in response to chronic infection with Porphyromonas gingivalis using bioinformatical analyses
  publication-title: Front Oncol.
  doi: 10.3389/fonc.2019.00091
  contributor:
    fullname: Geng
– volume: 38
  start-page: 1074
  year: 2016
  ident: 2020041521553931400_CIT0042
  article-title: Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma
  publication-title: Head Neck.
  doi: 10.1002/hed.24406
  contributor:
    fullname: Nguyen
– volume: 66
  start-page: 627
  year: 2017
  ident: 2020041521553931400_CIT0032
  article-title: Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma
  publication-title: Cancer Immunol Immunother.
  doi: 10.1007/s00262-017-1968-0
  contributor:
    fullname: Wu
– volume: 65
  start-page: 1035
  year: 2016
  ident: 2020041521553931400_CIT0031
  article-title: B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma
  publication-title: Cancer Immunol Immunother.
  doi: 10.1007/s00262-016-1867-9
  contributor:
    fullname: Wu
– volume: 12
  start-page: 624
  year: 2011
  ident: 2020041521553931400_CIT0012
  article-title: IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA
  publication-title: Nat Immunol.
  doi: 10.1038/ni.2048
  contributor:
    fullname: Pichlmair
– volume: 418
  start-page: 293
  year: 2002
  ident: 2020041521553931400_CIT0016
  article-title: A molecular programme for the specification of germ cell fate in mice
  publication-title: Nature.
  doi: 10.1038/nature00927
  contributor:
    fullname: Saitou
– volume: 6
  start-page: 42067
  year: 2015
  ident: 2020041521553931400_CIT0030
  article-title: PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma
  publication-title: Oncotarget.
  doi: 10.18632/oncotarget.5955
  contributor:
    fullname: Yu
– volume: 136
  start-page: E359
  year: 2015
  ident: 2020041521553931400_CIT0002
  article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
  publication-title: Int J Cancer.
  doi: 10.1002/ijc.29210
  contributor:
    fullname: Ferlay
– volume: 43
  start-page: 435
  year: 2015
  ident: 2020041521553931400_CIT0007
  article-title: Metabolic reprogramming of immune cells in cancer progression
  publication-title: Immunity.
  doi: 10.1016/j.immuni.2015.09.001
  contributor:
    fullname: Biswas
– volume: 14
  start-page: 36
  year: 2014
  ident: 2020041521553931400_CIT0010
  article-title: Regulation of type I interferon responses
  publication-title: Nat Rev Immunol.
  doi: 10.1038/nri3581
  contributor:
    fullname: Ivashkiv
– volume: 103
  start-page: 782
  year: 2012
  ident: 2020041521553931400_CIT0038
  article-title: Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon-inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation
  publication-title: Cancer Sci.
  doi: 10.1111/j.1349-7006.2012.02211.x
  contributor:
    fullname: Kondo
– volume: 47
  start-page: 352
  year: 2011
  ident: 2020041521553931400_CIT0033
  article-title: Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas
  publication-title: Oral Oncol.
  doi: 10.1016/j.oraloncology.2011.03.007
  contributor:
    fullname: Laimer
SSID ssj0012804
Score 2.4409955
Snippet Abstract Objectives Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly...
Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I...
Objectives: Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by...
The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed.
Objectives Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by...
OBJECTIVESInterferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by...
SourceID proquest
gale
crossref
pubmed
oup
SourceType Aggregation Database
Index Database
Publisher
StartPage 618
SubjectTerms Apoptosis
B7 antigen
Cell activation
Cell death
Dysplasia
Genetic aspects
Head & neck cancer
Head and neck cancer
Immune checkpoint
Immunoglobulins
Immunohistochemistry
Interferon
Lymphocytes T
Macrophages
Medical prognosis
Mucosa
Prognosis
Squamous cell carcinoma
Tissue microarrays
Tryptophan 2,3-dioxygenase
Title Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma
URI https://www.ncbi.nlm.nih.gov/pubmed/31977029
https://www.proquest.com/docview/2425571901
https://search.proquest.com/docview/2344264376
Volume 153
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BJhAvCMZXoAwjTeIpamI7tfOERtWqQ1o1wYb6gBQ5tiMNStJ2rQT89dwlbqFC2ksUxbEt3Z3Pv_Od7wBOBuTecypF4S1dLE0qKQekjLNKuNxKQZCZoi2mg8mV_DjLZuHA7SaEVW51YquoXWPpjLxP0DhTtH29XyxjqhpF3tVQQuMuHKYcwQTKs5rtDC5UvYncwl80S0S4n4dGfN98s4u-Wf7mVLfunx0p6OW9y27_Yc527xk_gocBNLLTjsuP4Y6vj-BeV0by1xHcPw8O8ifwdfQzRLbWzNSOXawaiqTDfuyLmW88ayp2Nj67TNtWejsX7LpmE2R1-2nq7Xf2ebkxdCTAhn4-Z0MqN1Q3P8xTuBqPLoeTOBRQiK3M-DrmAu27UvuMO1sKm1h8cmW1sAjDtJNOV84kXtlcl2nmhPS5SrSsEmWFUMaJZ3BQN7V_Acxqh8upoqI22FnxUicDXaVZyVOfu8REcLIlYrHo8mQUnX9bFETroqN1BO-IwAWtnvXKWBMuAeAklIeqOCU_K-pukUfQ2_sTpd7uNb9BFt0-VW_LviKsy5virxRF8HbXTGNTrFntkbQFF5JgImreCJ53bN_NgwpLqYTnL28f_BU84GSXU07IrAcH69XGv0bwsi6PWwk9hsMPo-nFpz-5J-of
link.rule.ids 315,786,790,12083,21416,27955,27956,31752,31753,33777,33778,43343,43838,74100,74657
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dixMxEB_0xI8X0dPT1epFOPBp6W6SbXaf5ChXWr0WwZ70QQjZJAtq3W17Lah_vTPdtFqEe1mWzSaBmcnkN5nJDMBZj9x7TqUovKWLpUkl5YCUcVYJV1gpCDJTtMWkN7yS72fZLBy4XYewyp1O3Cpq11g6I-8SNM4UbV_vFsuYqkaRdzWU0LgNd6QQkuRczfYGF6reRO7gL5olItzPQyO-a77ZRdcsf3OqW_fPjhT08sFlt_8w53bvGTyChwE0svOWy4_hlq-P4W5bRvLXMdwbBwf5E_hy8TNEttbM1I59XDUUSYf92Gcz33jWVGw0GE3TbSu9jQX7WrMhsnr7aeLtd_ZpuTF0JMD6fj5nfSo3VDc_zFO4GlxM-8M4FFCIrcz4OuYC7bsy9xl3thQ2sfjkyubCIgzLnXR55UzilS3yMs2ckL5QSS6rRFkhlHHiBI7qpvbPgdnc4XKqqKgNdla8zJNeXqVZyVNfuMREcLYjol60eTJ0698WmmitW1pH8JYIrGn1rFfGmnAJACehPFT6nPysqLtFEUHn4E-UenvQfIosunmqzo59OqzLa_1XiiJ4s2-msSnWrPZIWs2FJJiImjeCZy3b9_OgwlIq4cWLmwc_hfvD6fhSX44mH17CA042OuWHzDpwtF5t_CsEMuvy9VZa_wCAUety
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw8ARDTLwgGF-Bwow0iaeoie3UyROayqoWWDWJDfUByXJsRwJK0natBPx67hK3UCHtJYri2Jbu-3znO4CTAYX3nEqReEsXS5NKqgEp46wSrrBSkMlM2RbTwfhKvp9ls5D_dB3SKrcysRXUrrF0Rt4n0zhTpL76VUiLuHg3ertYxtRBiiKtoZ3GbbiDWjKhNg5qtnO-UAwncmsKo4siwl09dOj75ptd9M3yN6cedv9opyCj9y6-_Wd_tnpo9ADuBwOSnXYYfwi3fH0Ed7uWkr-O4PA8BMsfwZeznyHLtWamduxi1VBWHc5jn81841lTsclocpm2o_R2LtjXmo0R7e2nqbff2aflxtDxABv6-ZwNqfVQ3fwwj-FqdHY5HMehmUJsZcbXMRfo65W5z7izpbCJxSdXNhcWTbLcSZdXziRe2SIv08wJ6QuV5LJKlBVCGSeewEHd1P4ZMJs7ZK2KGtzgZMXLPBnkVZqVPPWFS0wEJ1sg6kVXM0N3sW6hCda6g3UEbwjAmjhpvTLWhAsBuAnVpNKnFHNFOS6KCHp7fyIH2L3hY0TRzVv1tujTgUev9V-KiuD1bpjWpryz2iNoNReSTEaUwhE87dC-2weFl1IJL57fvPgxHCKh6o-T6YcXcI-Tu06lIrMeHKxXG_8SbZp1-aol1j-juO-e
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+and+Prognostic+Value+of+IFIT1+and+IFITM3+in+Head+and+Neck+Squamous+Cell+Carcinoma&rft.jtitle=American+journal+of+clinical+pathology&rft.au=Li%2C+Hao&rft.au=Yang%2C+Lei-Lei&rft.au=Wu%2C+Cong-Cong&rft.au=Xiao%2C+Yao&rft.date=2020-04-15&rft.issn=0002-9173&rft.eissn=1943-7722&rft.volume=153&rft.issue=5&rft.spage=618&rft.epage=629&rft_id=info:doi/10.1093%2Fajcp%2Faqz205&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_ajcp_aqz205
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9173&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9173&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9173&client=summon